 | • レポートコード：TPM-B04001 • 出版社/出版日：Transparency Market Research / 2018年1月 • レポート形態：英文、PDF、159ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、インフルエンザ治療薬の世界市場について調べ、インフルエンザ治療薬の世界規模、市場動向、市場環境、製品別分析、流通経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、バリューチェーン分析、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・インフルエンザ治療薬の世界市場動向 ・インフルエンザ治療薬の世界市場環境 ・インフルエンザ治療薬のバリューチェーン分析 ・インフルエンザ治療薬の世界市場規模 ・インフルエンザ治療薬の世界市場規模：製品別 ・インフルエンザ治療薬の世界市場規模：流通経路別 ・インフルエンザ治療薬の世界市場：地域別市場規模・分析 ・インフルエンザ治療薬の北米市場規模・予測 ・インフルエンザ治療薬のアメリカ市場規模・予測 ・インフルエンザ治療薬の中南米市場規模・予測 ・インフルエンザ治療薬のヨーロッパ市場規模・予測 ・インフルエンザ治療薬のアジア市場規模・予測 ・インフルエンザ治療薬の日本市場規模・予測 ・インフルエンザ治療薬の中国市場規模・予測 ・インフルエンザ治療薬のインド市場規模・予測 ・インフルエンザ治療薬の中東市場規模・予測 ・インフルエンザ治療薬のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Influenza Medication Market: Overview
This report on Influenza Medication Market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of Influenza Medication Market products such as Zanamivir, Oseltamivir, Peramivir, and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the Global Influenza Medication Market with respect to the leading market segments based on products segment, distribution channels, and geographies.
Global Influenza Medication Market: Key Segments
Based on the product type, the Influenza Medication Market has been segmented into: Zanamivir, Oseltamivir, Peramivir, Amantadine, Rimantadine, Inosine and Others (laninamivir octanoate, etc.). Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of Influenza Medication Market products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Influenza Medication Market: Scope of the Study
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the Influenza Medication Market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global influenza medication market.
Global Influenza Medication Market: Regional Outlook
Geographically, influenza medication market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the Global Influenza Medication Market.
Companies Mentioned in Report
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the Global Influenza Medication Market. The report also profiles key players operating in the Influenza Medication Market which are Daiichi Sankyo Company, GlaxoSmithKline plc, Natco Pharma, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH (Novartis AG), Sun Pharmaceutical Industries Ltd. and Mylan, Inc..
The global influenza medication market is segmented as follows:
Global Influenza Medication Market, by Product
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other (Laninamivir Octanoate, etc.)
Global Influenza Medication Market, by Distribution channel
Hospitals
Clinics
Pharmacies
Others
Global Influenza Medication Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Poland
Rest of the Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Rest of Middle East & Africa
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology
3. Executive Summary
3.1. Global Influenza Medication Market Snapshot
4. Market Overview
4.1. Product Overview
4.2. Key Industry Events
4.3. Global Influenza Medication Market Size (US$ Mn) Forecast, 2015-2025
4.4. Market Opportunity Map
4.5. Porter’s Five Forces Analysis
4.6. Value Chain Analysis
4.7. Global Influenza Medication Market Outlook
4.8. Major Revenue Pockets Analysis
4.9. Market Penetration Strategies
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increase in prevalence and incidence of influenza
5.2.2. Strong R&D focus resulting in new and advanced treatments and drugs
5.2.3. Fast acceptance by physicians and drug formularies
5.2.4. Outbreak of pandemic influenza
5.2.5. for treatment and prevention of influenza
5.2.6. Increasing government expenditure on health care
5.3. Restraints
5.3.1. High cost of drug development
5.3.2. Side effects of antiviral therapy
5.4. Opportunities
5.4.1. Product development through partnerships
5.4.2. Alternative mechanisms that might have higher efficacy and fewer side effects
6. Global Influenza Medication Market Analysis, by Product
6.1. Introduction
6.2. Key Findings
6.3. Global Influenza Medication Market Value Share Analysis, by Product
6.4. Global Influenza Medication Market Forecast, by Product
6.4.1. Zanamivir
6.4.2. Oseltamivir
6.4.3. Peramivir
6.4.4. Amantadine
6.4.5. Rimantadine
6.4.6. Inosine
6.4.7. Other (Laninamivir Octanoate, etc.)
6.5. Global Influenza Medication Market Analysis, by Product
6.6. Global Influenza Medication Market Attractiveness Analysis, by Product
7. Global Influenza Medication Market Analysis, by Distribution Channel
7.1. Introduction
7.2. Key Findings
7.3. Global Influenza Medication Market Value Share Analysis, by Distribution Channel
7.4. Global Influenza Medication Market Forecast, by Distribution Channel
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Pharmacies
7.4.4. Others
7.5. Global Influenza Medication Market Analysis, by Distribution Channel
7.6. Global Influenza Medication Market Attractiveness Analysis, by Distribution Channel
8. Global Influenza Medication Market Analysis, by Region
8.1. Global Market Scenario by Country
8.2. Global Influenza Medication Market Value Share Analysis, by Region
8.3. Global Influenza Medication Market Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4. Global Influenza Medication Market Attractiveness Analysis, by Region
9. North America Influenza Medication Market Analysis
9.1. Key Findings
9.2. North America Influenza Medication Market Overview
9.3. North America Influenza Medication Market Value Share Analysis, by Country
9.4. North America Influenza Medication Market Forecast, by Country
9.4.1. U.S.
9.4.2. Canada
9.5. North America Influenza Medication Market Value Share Analysis, by Product
9.6. North America Influenza Medication Market Value Share Analysis, by Product
9.7. North America Influenza Medication Market Forecast, by Product
9.8. North America Influenza Medication Market Value Share Analysis, by Distribution Channel
9.9. North America Influenza Medication Market Forecast, by Distribution Channel
9.10. North America Influenza Medication Market Attractiveness Analysis
9.11. Key Trends
10. Europe Influenza Medication Market Analysis
10.1. Key Findings
10.2. Europe Influenza Medication Market Overview
10.3. Europe Influenza Medication Market Value Share Analysis, by Country
10.4. Europe Influenza Medication Market Forecast, by Country
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Poland
10.4.7. Rest of the Europe
10.5. Europe Influenza Medication Market Value Share Analysis, by Product
10.6. Europe Influenza Medication Market Value Share Analysis, by Product
10.7. Europe Influenza Medication Market Forecast, by Product
10.8. Europe Influenza Medication Market Value Share Analysis, by Distribution Channel
10.9. Europe Influenza Medication Market Forecast, by Distribution Channel
10.10. Europe Influenza Medication Market Attractiveness Analysis
10.11. Key Trends
11. Asia Pacific Influenza Medication Market Analysis
11.1. Key Findings
11.2. Asia Pacific Influenza Medication Market Overview
11.3. Asia Pacific Influenza Medication Market Value Share Analysis, by Country
11.4. Asia Pacific Influenza Medication Market Forecast, by Country
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. South Korea
11.4.6. Rest of Asia Pacific
11.5. Asia Pacific Influenza Medication Market Value Share Analysis, by Product
11.6. Asia Pacific Influenza Medication Market Value Share Analysis, by Product
11.7. Asia Pacific Influenza Medication Market Forecast, by Product
11.8. Asia Pacific Influenza Medication Market Value Share Analysis, by Distribution Channel
11.9. Asia Pacific Influenza Medication Market Forecast, by Distribution Channel
11.10. Asia Pacific Influenza Medication Market Attractiveness Analysis
11.11. Key Trends
12. Latin America Influenza Medication Market Analysis
12.1. Key Findings
12.2. Latin America Influenza Medication Market Overview
12.3. Latin America Influenza Medication Market Value Share Analysis, by Country
12.4. Latin America Influenza Medication Market Forecast, by Country
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Influenza Medication Market Value Share Analysis, by Product
12.6. Latin America Influenza Medication Market Value Share Analysis, by Product
12.7. Latin America Influenza Medication Market Forecast, by Product
12.8. Latin America Influenza Medication Market Value Share Analysis, by Distribution Channel
12.9. Latin America Influenza Medication Market Forecast, by Distribution Channel
12.10. Rest of World Influenza Medication Market Attractiveness Analysis
12.11. Key Trends
13. Middle East and Africa Influenza Medication Market Analysis
13.1. Key Findings
13.2. Middle East and Africa Influenza Medication Market Overview
13.3. Middle East and Africa Influenza Medication Market Value Share Analysis, by Country
13.4. Middle East and Africa Influenza Medication Market Forecast, by Country
13.4.1. South Africa
13.4.2. Saudi Arabia
13.4.3. UAE
13.4.4. Rest of Middle East & Africa
13.5. Middle East and Africa Influenza Medication Market Value Share Analysis, by Product
13.6. Middle East and Africa Influenza Medication Market Value Share Analysis, by Product
13.7. Middle East and Africa Influenza Medication Market Forecast, by Product
13.8. Middle East and Africa Influenza Medication Market Value Share Analysis, by Distribution Channel
13.9. Middle East and Africa Influenza Medication Market Forecast, by Distribution Channel
13.10. Middle East and Africa Influenza Medication Market Attractiveness Analysis
13.11. Key Trends
14. Competition Landscape
14.1. Competition Matrix
14.2. Company Profiles
14.2.1. F. Hoffmann-La Roche Ltd.
14.2.1.1. Company Details
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Teva Pharmaceutical Industries Ltd.
14.2.2.1. Company Details
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. Sandoz International GmbH (Novartis AG)
14.2.3.1. Company Details
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Sun Pharmaceutical Industries Ltd.
14.2.4.1. Company Details
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. Mylan, Inc.
14.2.5.1. Company Details
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. GlaxoSmithKline plc
14.2.6.1. Company Details
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. Daiichi Sankyo Company
14.2.7.1. Company Details
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Natco Pharma
14.2.8.1. Company Details
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
Table 01: Global Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 03: Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Region, 2015–2025
Table 04: North America Influenza Medication Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 05: North America Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 06: North America Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 07: Europe Influenza Medication Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 08: Europe Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 09: Europe Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 10: Asia Pacific Influenza Medication Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 11: Asia Pacific Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 12: Asia Pacific Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channels, 2015–2025
Table 13: Latin America Influenza Medication Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Latin America Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 15: Latin America Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Middle East & Africa Influenza Medication Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Middle East & Africa Influenza Medication Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 18: Middle East & Africa Influenza Medication Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025